Annual Cash & Cash Equivalents
$38.68 M
-$22.79 M-37.07%
31 December 2023
Summary:
AMERISAFE annual cash & cash equivalents is currently $38.68 million, with the most recent change of -$22.79 million (-37.07%) on 31 December 2023. During the last 3 years, it has fallen by -$23.07 million (-37.36%). AMSF annual cash & cash equivalents is now -68.57% below its all-time high of $123.08 million, reached on 31 December 2013.AMSF Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$63.66 M
+$33.05 M+107.97%
30 September 2024
Summary:
AMERISAFE quarterly cash and cash equivalents is currently $63.66 million, with the most recent change of +$33.05 million (+107.97%) on 30 September 2024. Over the past year, it has increased by +$4.41 million (+7.45%). AMSF quarterly cash and cash equivalents is now -49.42% below its all-time high of $125.87 million, reached on 30 September 2019.AMSF Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMSF Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -37.1% | +7.5% |
3 y3 years | -37.4% | -48.3% |
5 y5 years | -4.1% | -49.4% |
AMSF Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -45.3% | at low | -48.3% | +108.0% |
5 y | 5 years | -45.3% | at low | -49.4% | +108.0% |
alltime | all time | -68.6% | +52.2% | -49.4% | +200.6% |
AMERISAFE Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $63.66 M(+108.0%) |
June 2024 | - | $30.61 M(-8.3%) |
Mar 2024 | - | $33.38 M(-13.7%) |
Dec 2023 | $38.68 M(-37.1%) | $38.68 M(-34.7%) |
Sept 2023 | - | $59.25 M(+74.7%) |
June 2023 | - | $33.92 M(-17.7%) |
Mar 2023 | - | $41.21 M(-33.0%) |
Dec 2022 | $61.47 M(-13.1%) | $61.47 M(-32.4%) |
Sept 2022 | - | $90.95 M(+6.6%) |
June 2022 | - | $85.32 M(+177.5%) |
Mar 2022 | - | $30.74 M(-56.5%) |
Dec 2021 | $70.72 M(+14.5%) | $70.72 M(-42.6%) |
Sept 2021 | - | $123.13 M(+114.0%) |
June 2021 | - | $57.54 M(+74.0%) |
Mar 2021 | - | $33.07 M(-46.4%) |
Dec 2020 | $61.76 M(+41.0%) | $61.76 M(-30.0%) |
Sept 2020 | - | $88.17 M(-20.1%) |
June 2020 | - | $110.28 M(+38.7%) |
Mar 2020 | - | $79.52 M(+81.5%) |
Dec 2019 | $43.81 M(+8.6%) | $43.81 M(-65.2%) |
Sept 2019 | - | $125.87 M(+145.6%) |
June 2019 | - | $51.25 M(+46.9%) |
Mar 2019 | - | $34.90 M(-13.5%) |
Dec 2018 | $40.34 M(-27.4%) | $40.34 M(+21.1%) |
Sept 2018 | - | $33.32 M(+57.4%) |
June 2018 | - | $21.18 M(-41.3%) |
Mar 2018 | - | $36.07 M(-35.1%) |
Dec 2017 | $55.56 M(-5.7%) | $55.56 M(-30.9%) |
Sept 2017 | - | $80.38 M(+48.9%) |
June 2017 | - | $53.97 M(+37.1%) |
Mar 2017 | - | $39.35 M(-33.2%) |
Dec 2016 | $58.94 M(-15.2%) | $58.94 M(-32.0%) |
Sept 2016 | - | $86.61 M(+23.5%) |
June 2016 | - | $70.16 M(-11.5%) |
Mar 2016 | - | $79.29 M(+14.1%) |
Dec 2015 | $69.48 M(-23.6%) | $69.48 M(-30.4%) |
Sept 2015 | - | $99.90 M(+62.2%) |
June 2015 | - | $61.59 M(-22.8%) |
Mar 2015 | - | $79.73 M(-12.3%) |
Dec 2014 | $90.96 M | $90.96 M(-23.3%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2014 | - | $118.54 M(+20.0%) |
June 2014 | - | $98.82 M(-7.5%) |
Mar 2014 | - | $106.86 M(-13.2%) |
Dec 2013 | $123.08 M(+32.8%) | $123.08 M(+5.4%) |
Sept 2013 | - | $116.78 M(+40.0%) |
June 2013 | - | $83.42 M(+10.8%) |
Mar 2013 | - | $75.29 M(-18.8%) |
Dec 2012 | $92.68 M(+103.5%) | $92.68 M(+33.6%) |
Sept 2012 | - | $69.34 M(-9.8%) |
June 2012 | - | $76.85 M(+20.5%) |
Mar 2012 | - | $63.77 M(+40.1%) |
Dec 2011 | $45.54 M(-25.3%) | $45.54 M(-33.9%) |
Sept 2011 | - | $68.94 M(+11.1%) |
June 2011 | - | $62.04 M(+18.9%) |
Mar 2011 | - | $52.20 M(-14.4%) |
Dec 2010 | $60.97 M(-3.5%) | $60.97 M(+11.2%) |
Sept 2010 | - | $54.82 M(+9.3%) |
June 2010 | - | $50.14 M(-22.0%) |
Mar 2010 | - | $64.26 M(+1.7%) |
Dec 2009 | $63.19 M(-33.7%) | $63.19 M(-39.7%) |
Sept 2009 | - | $104.83 M(+27.6%) |
June 2009 | - | $82.15 M(-11.2%) |
Mar 2009 | - | $92.47 M(-2.9%) |
Dec 2008 | $95.24 M(+101.2%) | $95.24 M(+33.8%) |
Sept 2008 | - | $71.18 M(+31.2%) |
June 2008 | - | $54.25 M(-30.1%) |
Mar 2008 | - | $77.59 M(+63.9%) |
Dec 2007 | $47.33 M(+76.9%) | $47.33 M(+3.5%) |
Sept 2007 | - | $45.72 M(-6.1%) |
June 2007 | - | $48.70 M(+9.4%) |
Mar 2007 | - | $44.51 M(+66.4%) |
Dec 2006 | $26.75 M(-45.7%) | $26.75 M(-56.7%) |
Sept 2006 | - | $61.78 M(+98.1%) |
June 2006 | - | $31.19 M(-30.4%) |
Mar 2006 | - | $44.83 M(-9.0%) |
Dec 2005 | $49.29 M(+93.9%) | $49.29 M |
Dec 2004 | $25.42 M(-49.0%) | - |
Dec 2003 | $49.81 M(+11.5%) | - |
Dec 2002 | $44.68 M(-0.5%) | - |
Dec 2000 | $44.91 M | - |
FAQ
- What is AMERISAFE annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AMERISAFE?
- What is AMERISAFE annual cash & cash equivalents year-on-year change?
- What is AMERISAFE quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for AMERISAFE?
- What is AMERISAFE quarterly cash and cash equivalents year-on-year change?
What is AMERISAFE annual cash & cash equivalents?
The current annual cash & cash equivalents of AMSF is $38.68 M
What is the all time high annual cash & cash equivalents for AMERISAFE?
AMERISAFE all-time high annual cash & cash equivalents is $123.08 M
What is AMERISAFE annual cash & cash equivalents year-on-year change?
Over the past year, AMSF annual cash & cash equivalents has changed by -$22.79 M (-37.07%)
What is AMERISAFE quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AMSF is $63.66 M
What is the all time high quarterly cash and cash equivalents for AMERISAFE?
AMERISAFE all-time high quarterly cash and cash equivalents is $125.87 M
What is AMERISAFE quarterly cash and cash equivalents year-on-year change?
Over the past year, AMSF quarterly cash and cash equivalents has changed by +$4.41 M (+7.45%)